Article

Acylcarnitines metabolism in depression: association with diagnostic status, depression severity and symptom profile in the NESDA cohort

2024-08-11

Abstract excerpt

<title>Abstract</title> <p>Acylcarnitines (ACs) are involved in bioenergetics processes that may play a role in the pathophysiology of depression. Previous genomic evidence identified four ACs potentially linked to depression risk. We carried forward these ACs and tested the association of their circulating levels with Major Depressive Disorder (MDD) diagnosis, overall depression severity and specific symptom pro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ba43f30a-54fa-5b43-a34b-e553234eb7a0
DOI: 10.21203/rs.3.rs-4638158/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Acylcarnitines metabolism in depression: association with diagnostic status, depression severity and symptom profile in the NESDA cohortDOI 10.21203/rs.3.rs-4638158/v1Read

Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypes.Semantic proximity Read

Acylcarnitine Metabolomic Profiles Inform Clinically-Defined Major Depressive PhenotypesSemantic proximity Read

The Metabolome-Wide Signature of Major Depressive DisorderSemantic proximity Read

Peripheral Metabolic-Redox Signaling as a Core Mechanism of Major Depressive Disorder: Evidence From Deep Metabolomic PhenotypingSemantic proximity Read

Atypical energy-related symptoms define biologically distinct subtypes of major depressive disorderSemantic proximity Read

Atypical depression is associated with a distinct clinical, neurobiological, treatment response and polygenic risk profileSemantic proximity Read

Depression with atypical neurovegetative symptoms shares genetic predisposition with immuno-metabolic traits and alcohol consumption.Semantic proximity Read

Rare variants and biological pathways identified in treatment-refractory depression.Semantic proximity Read

Peripheral metabolic-redox signaling as a core mechanism of major depressive disorder: evidence from deep metabolomic phenotyping.Semantic proximity Read

Deep Lipidomic Phenotyping Identifies Ceramide-Centered Lipotoxicity and Depletion of Plasmalogen-Carnitine Pathways in Major Depressive Disorder: Implications for Precision MedicineSemantic proximity Read

Focus on fatty acids in the neurometabolic pathophysiology of psychiatric disordersSemantic proximity Read

Energy metabolism in major depressive disorder: Recent advances from omics technologies and imagingSemantic proximity Read